TG Therapeutics (TGTX) News Today

$13.98
-0.27 (-1.89%)
(As of 04/24/2024 ET)
SourceHeadline
markets.businessinsider.com logoBank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)
markets.businessinsider.com - April 23 at 7:42 PM
MarketBeat logoJPMorgan Chase & Co. Reiterates "Overweight" Rating for TG Therapeutics (NASDAQ:TGTX)
americanbankingnews.com - April 20 at 2:26 AM
MarketBeat logoTG Therapeutics (NASDAQ:TGTX) Stock Rating Reaffirmed by HC Wainwright
americanbankingnews.com - April 20 at 2:26 AM
MarketBeat logoTG Therapeutics (NASDAQ:TGTX) Stock Rating Reaffirmed by LADENBURG THALM/SH SH
americanbankingnews.com - April 20 at 1:30 AM
marketbeat.com logoTG Therapeutics (NASDAQ:TGTX) Stock Price Up 4.8%
marketbeat.com - April 18 at 4:55 PM
marketbeat.com logoTG Therapeutics (NASDAQ:TGTX) Earns "Overweight" Rating from JPMorgan Chase & Co.
marketbeat.com - April 18 at 2:21 PM
globenewswire.com logoTG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
globenewswire.com - April 18 at 7:30 AM
globenewswire.com logoTG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
globenewswire.com - April 18 at 7:00 AM
seekingalpha.com logoTG Therapeutics: The Cloud Over Briumvi
seekingalpha.com - April 17 at 10:24 AM
msn.com logoTG Posts Gains on Results of MS Drug Test
msn.com - April 15 at 1:50 PM
globenewswire.com logoTG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
globenewswire.com - April 15 at 7:30 AM
globenewswire.com logoTG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
globenewswire.com - April 15 at 7:30 AM
nasdaq.com logoTG Therapeutics Breaks Below 200-Day Moving Average - Notable for TGTX
nasdaq.com - April 14 at 8:16 PM
marketbeat.com logoTG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Recommendation of "Moderate Buy" from Brokerages
marketbeat.com - April 14 at 2:12 AM
seekingalpha.com logoTG Therapeutics: BRIUMVI Development Could Lead To Great Results
seekingalpha.com - April 12 at 8:00 PM
marketbeat.com logoTG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Rating of "Moderate Buy" from Brokerages
marketbeat.com - March 20 at 3:41 AM
finance.yahoo.com logoIs TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals?
finance.yahoo.com - March 19 at 10:29 AM
investing.com logoTg therapeutics director sells shares worth over $79k
investing.com - March 17 at 9:24 AM
finance.yahoo.com logoTGTX Mar 2024 20.500 call
finance.yahoo.com - March 16 at 1:08 PM
finance.yahoo.com logoTGTX Mar 2024 16.500 put
finance.yahoo.com - March 16 at 1:08 PM
finance.yahoo.com logoTGTX Apr 2024 19.500 call
finance.yahoo.com - March 16 at 3:07 AM
finance.yahoo.com logoTGTX Apr 2024 11.000 put
finance.yahoo.com - March 16 at 3:07 AM
finance.yahoo.com logoTGTX Apr 2024 23.000 call
finance.yahoo.com - March 15 at 5:06 PM
finance.yahoo.com logoTGTX Apr 2024 16.000 put
finance.yahoo.com - March 15 at 5:06 PM
marketbeat.com logoJacobs Levy Equity Management Inc. Purchases 145,667 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX)
marketbeat.com - March 15 at 4:16 AM
insidertrades.com logoLaurence N. Charney Sells 22,000 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) Stock
insidertrades.com - March 14 at 9:39 AM
marketbeat.com logoTG Therapeutics (NASDAQ:TGTX) Shares Down 3.9%
marketbeat.com - March 8 at 1:45 PM
globenewswire.com logoTG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
globenewswire.com - March 8 at 7:30 AM
marketbeat.com logoFmr LLC Lowers Position in TG Therapeutics, Inc. (NASDAQ:TGTX)
marketbeat.com - March 8 at 4:25 AM
nasdaq.com logoValidea Detailed Fundamental Analysis - TGTX
nasdaq.com - March 6 at 4:14 PM
finance.yahoo.com logoTGTX Mar 2024 19.500 call
finance.yahoo.com - March 3 at 6:20 PM
finance.yahoo.com logoTGTX Mar 2024 18.000 put
finance.yahoo.com - March 3 at 6:20 PM
marketbeat.com logoSchonfeld Strategic Advisors LLC Has $11.43 Million Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)
marketbeat.com - March 3 at 8:20 AM
marketbeat.com logo683 Capital Management LLC Invests $11.29 Million in TG Therapeutics, Inc. (NASDAQ:TGTX)
marketbeat.com - March 1 at 10:35 AM
seekingalpha.com logoTG Therapeutics: Briumvi Growth Story Appears Intact
seekingalpha.com - March 1 at 8:50 AM
marketbeat.com logoBrokers Issue Forecasts for TG Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:TGTX)
marketbeat.com - March 1 at 8:45 AM
globenewswire.com logoTG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
globenewswire.com - March 1 at 7:30 AM
finance.yahoo.com logoTG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 29 at 11:42 AM
marketbeat.com logoHC Wainwright Comments on TG Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:TGTX)
marketbeat.com - February 29 at 9:29 AM
marketbeat.com logoTG Therapeutics (NASDAQ:TGTX) Price Target Raised to $13.00 at The Goldman Sachs Group
marketbeat.com - February 29 at 8:33 AM
realmoney.thestreet.com logoTG Therapeutics price target raised by $1 at Goldman Sachs, here's why
realmoney.thestreet.com - February 28 at 10:58 PM
finance.yahoo.com logoQ4 2023 TG Therapeutics Inc Earnings Call
finance.yahoo.com - February 28 at 10:58 PM
msn.com logoWhy Is Multiple Sclerosis-Focused TG Therapeutics Stock Trading Higher Today?
msn.com - February 28 at 5:58 PM
finance.yahoo.com logoTG Therapeutics Inc (TGTX) Announces Fourth Quarter and Full Year 2023 Financial Results
finance.yahoo.com - February 28 at 12:57 PM
msn.com logoTG Therapeutics jumps after second consecutive quarterly beat
msn.com - February 28 at 12:57 PM
finance.yahoo.com logoTG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
finance.yahoo.com - February 28 at 12:57 PM
marketbeat.com logoTG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX)
marketbeat.com - February 28 at 11:27 AM
marketbeat.com logoHC Wainwright Equities Analysts Boost Earnings Estimates for TG Therapeutics, Inc. (NASDAQ:TGTX)
marketbeat.com - February 28 at 8:23 AM
msn.com logoTG Therapeutics GAAP EPS of -$0.09 beats by $0.02, revenue of $40M misses by $0.06M
msn.com - February 28 at 7:56 AM
globenewswire.com logoTG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
globenewswire.com - February 28 at 7:00 AM
Get TG Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter.

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

TGTX Media Mentions By Week

TGTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TGTX
News Sentiment

0.10

0.44

Average
Medical
News Sentiment

TGTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TGTX Articles
This Week

11

5

TGTX Articles
Average Week

Get TG Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TGTX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners